Salafloxacin is a new animal drug after Enoxacin. The antibacterial activity of salafloxacin is stronger than that of difloxacin, Norfloxacin, ofloxacin - amikacin and tobramycin, etc., and the antibacterial activity of salafloxacin against anaerobic bacteria is comparable to that of ciprofloxacin.

Antibacterial, for e. coli, salmonella, kill pap coli, proteus, haemophilus, hemolytic pap coli, staphylococcus aureus (including resistance to penicillin bacterium bead), streptococcus pneumoniae, mycoplasma, etc have a stronger role in killing suppression, the former three MIC90 (ug/ml) was 0.06, 0.06 and 0.015, respectively, at the same time also has more after antibacterial effect.

Pharmacokinetics: The product is absorbed rapidly by internal administration and injection.Widely distributed in the body, the apparent volume of distribution is large, internal bioavailability is high, eliminate half-life indications: antimicrobial drugs.
It has a strong killing effect on gram-positive bacteria, negative bacteria and mycoplasma.

Packing:  

1kg/bag,  25kgs/drum (Two plastic-bags inside and  Paper-drums  or per customer's requirements.)

Storage:

Store in tight, light-resistant containers, avoid exposure to direct sunlight, moisture and excessive heat.
Shelf Life: 24 months.